Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: Verifi Test Validation Results
Figure 3-2: Panorma Test Validation Results
Figure 3-3: Harmony Test Validation Results
Figure 5-1: Risk of Down’s syndrome with Rise in Maternal Age
Figure 6-1: Population (Million), 2013-2018
Figure 6-2: Male- Female Ratio (%), 2013
Figure 6-3: Number of Births (Million), 2009-2013
Figure 6-4: Number of Births (Million), 2014-2018
Figure 7-1: Number of Births by Mother’s Risk of Down’s syndrome (%), 2013
Figure 7-2: High Risk NIPT Potential Market (Million US$), 2013 & 2018
Figure 7-3: Medium Risk NIPT Potential Market (Million US$), 2013 & 2018
Figure 8-1: Non-Invasive Prenatal Diagnostics Market (Million US$), 2013-2018
Figure 8-2: NIPT Market Penetration in High Risk Category (2013)
Figure 8-3: Share of Players in Number of NIPT Tests Performed (2013)
Figure 8-4: Share of Players in NIPT Market (2013)
Figure 8-5: Forecast for Share of Players in Number of NIPT Tests Performed (2018)
Figure 8-6: Forecast for Share of Players in NIPT Market (2018)
Figure 9-1: Laboratorians’ Attitudes towards FDAs Regulations on Lab Developed Tests (LDT)

List of Tables:

Table 3-1: Comparison of Features of Key NIPT Tests in APAC NIPT Market
Table 3-2: MaterniT21 PLUS Test Validation Results
Table 4-1: Common Commercial Kits and Protocols for Isolation of ccff DNA from Maternal Plasma
Table 6-1: Births by Women Age-Group (%), 2010-2013
Table 6-2: Top Ten States by Number of Births (2011 & 2012)
Table 6-3: Prevalence of Chromosomal Abnormalities
Table 9-1: Inter-comparison of CLIA and FDA Regulatory Pathway
Table 10-1: Comparative Analysis of Tests Available in US NIPT Market